Change in Hepatitis B Virus Large Surface Antigen Variant Prevalence 13 Years after Implementation of a Universal Vaccination Program in China

被引:56
作者
Bian, Tao [1 ,2 ]
Yan, Hongxia [1 ,3 ]
Shen, Liping [1 ]
Wang, Feng [1 ]
Zhang, Shuang [1 ]
Cao, Yanqiang [4 ]
Zhang, Shuo [1 ]
Zhang, Yong [1 ]
Bi, Shengli [1 ]
机构
[1] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China
[2] Univ N Carolina, Eshelman Sch Pharm, Div Mol Pharmaceut, Chapel Hill, NC USA
[3] Bur Hlth Inspect & Supervis Chaoyang Dist, Beijing, Peoples R China
[4] Hebei Entry Exit Inspect & Quarantine Bur, Shijiazhuang, Peoples R China
关键词
S-GENE; MOLECULAR EPIDEMIOLOGY; DETERMINANT VARIANTS; HBS ANTIBODIES; ESCAPE MUTANT; INFECTION; MUTATIONS; CHILDREN; CARRIERS; SECRETION;
D O I
10.1128/JVI.02127-13
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A nationwide hepatitis B virus (HBV) vaccination program was implemented in China starting in 1992. To study the change in HBV variant prevalence with massive immunization, large HBV surface protein (LHBs) genes from HBV surface antigen (HBsAg)-positive sera were amplified and sequenced. The prevalences of LHBs mutants were compared between the 1992 and 2005 surveys in child and adult groups. The prevalence of "alpha" determinant mutants in the children increased from 6.5% in 1992 to 14.8% in 2005, where the G145R mutant occurred most frequently. In contrast, mutation frequencies showed little difference between 1992 (9.4%) and 2005 (9.9%) in adults. Moreover, compared to the 1992 survey, the child group surface (S) protein mutation frequency specifically increased (P = 0.005) in the 2005 survey, but the pre-S region mutation frequency did not show a significant difference (P > 0.05). However, the mutation frequency in the adult group increased in both the pre-S and S regions. Furthermore, the frequencies of the disease-related pre-S2 deletion and start codon mutations were significantly higher in the adult groups than in the child groups in both the 1992 and 2005 surveys (P < 0.01). Massive immunization enhances the HBV S protein mutation; the prevalence of LHBs mutants, particularly disease-related mutants, tends to increase with patient age.
引用
收藏
页码:12196 / 12206
页数:11
相关论文
共 50 条
  • [41] The kinetics of the hepatitis B surface antigen level after the initiation of antiretroviral therapy for hepatitis B virus and human immunodeficiency virus coinfected patients
    Mitsumoto, Fujiko
    Murata, Masayuki
    Ura, Kazuya
    Takayama, Koji
    Hiramine, Satoshi
    Shimizu, Motohiro
    Toyoda, Kazuhiro
    Ogawa, Eiichi
    Furusyo, Norihiro
    Hayashi, Jun
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2015, 21 (3-4) : 264 - 271
  • [42] Changes in seroprevalence of hepatitis A after the implementation of universal childhood vaccination in Shandong Province, China: A comparison between 2006 and 2014
    Yan, Bing-yu
    Lv, Jing-jing
    Liu, Jia-ye
    Feng, Yi
    Wu, Wen-long
    Xu, Ai-qiang
    Zhang, Li
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2019, 82 : 129 - 134
  • [43] First evaluation of the serum level of anti-hepatitis B surface antigen after vaccination in Libya
    Madour, A.
    Alkout, A.
    Vanin, S.
    EASTERN MEDITERRANEAN HEALTH JOURNAL, 2013, 19 (12) : 990 - 994
  • [44] Economic analysis of the first 20 years of universal hepatitis B vaccination program in Italy An a posteriori evaluation and forecast of future benefits
    Boccalini, Sara
    Taddei, Cristina
    Ceccherini, Vega
    Bechini, Angela
    Levi, Miriam
    Bartolozzi, Dario
    Bonanni, Paolo
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2013, 9 (05) : 1119 - 1128
  • [45] Incidence of hepatitis B virus infection in young Chinese blood donors born after mandatory implementation of neonatal hepatitis B vaccination nationwide
    Tang, X.
    Allain, J. -P.
    Wang, H.
    Rong, X.
    Chen, J.
    Huang, K.
    Xu, R.
    Wang, M.
    Huang, J.
    Liao, Q.
    Shan, Z.
    Luo, S.
    Li, T.
    Li, C.
    Fu, Y.
    JOURNAL OF VIRAL HEPATITIS, 2018, 25 (09) : 1008 - 1016
  • [46] Intrahepatic hepatitis B virus large surface antigen induces hepatocyte hyperploidy via failure of cytokinesis
    Li, Tian-Neng
    Wu, Yi-Ju
    Tsai, Hung-Wen
    Sun, Cheng-Pu
    Wu, Yi-Hsuan
    Wu, Hui-Lin
    Pei, Yi-Ning
    Lu, Kuan-Ying
    Yen, Tim Ting-Chung
    Chang, Chien-Wen
    Chan, Hong-Lin
    Tao, Mi-Hua
    Liou, Jun-Yang
    Chang, Margaret Dah-Tsyr
    Su, Ih-Jen
    Wang, Lily Hui-Ching
    JOURNAL OF PATHOLOGY, 2018, 245 (04) : 502 - 513
  • [47] Emergence of Hepatitis B Virus S Gene Mutants in Patients Experiencing Hepatitis B Surface Antigen Seroconversion After Peginterferon Therapy
    Hsu, Chao-Wei
    Yeh, Chau-Ting
    HEPATOLOGY, 2011, 54 (01) : 101 - 108
  • [48] Prevalence and clinical characteristics of hepatitis B surface antigen-negative/hepatitis B core antibody-positive patients with detectable serum hepatitis B virus DNA
    Cai, Jingyao
    Wu, Weimin
    Wu, Jiali
    Chen, Zhiyang
    Wu, Ziwei
    Tang, Yamei
    Hu, Min
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (01)
  • [49] Circulating interferon-λ3 and post-vaccination antibodies against the surface antigen of hepatitis B virus in hemodialysis patients exposed to hepatitis E virus
    Grzegorzewska, Alicja E.
    Swiderska, Monika K.
    Winnicka, Hanna
    Niepolski, Leszek
    Bura, Maciej
    Lagiedo-Zelazowska, Malgorzata
    Jagodzinski, Pawel P.
    CYTOKINE, 2019, 123
  • [50] Hepatitis B Virus Antibody Levels 7 to 9 Years after Booster Vaccination in Alaska Native Persons
    Keck, James W.
    Bulkow, Lisa R.
    Raczniak, Gregory A.
    Negus, Susan E.
    Zanis, Carolyn L.
    Bruce, Michael G.
    Spradling, Philip R.
    Teshale, Eyasu H.
    McMahon, Brian J.
    CLINICAL AND VACCINE IMMUNOLOGY, 2014, 21 (09) : 1339 - 1342